Prognosis Daily: Coronavirus

By Bloomberg

Listen to a podcast, please open Podcast Republic app. Available on Google Play Store.


Category: Health

Open in Apple Podcasts


Open RSS feed


Open Website


Rate for this podcast

Subscribers: 283
Reviews: 0

Description

Harnessing Bloomberg's reporting from every continent, Bloomberg's daily Prognosis podcast brings the news, data and analysis you need for living in the time of Covid-19. In around ten minutes, we will explain the latest developments in health and science, the impact on individuals, industries and governments and the adaptations they are making in the face of the global pandemic. Come back every weekday afternoon for a short dose of the best information about the novel coronavirus from more than 120 bureaus around the world.

Episode Date
The Cost of Keeping Schools Safe
785
Arne Duncan, the former US secretary of education, recently warned a House panel against opening schools prematurely. He’s one of a growing chorus of voices sounding the alarm about opening schools without properly funding safety measures. The schools, they say, simply don’t have the money they need to make their buildings safe for students and teachers. At that same house panel, witnesses said public schools would need $200 billion in federal aid to open safely with the virus continuing to circulate. Skylar Woodhouse reports on costs, and challenges, of creating safe classrooms.
Aug 10, 2020
A Generation of Health Damage
922
The coronavirus has been spreading worldwide for over seven months now, and more than 18 million people are known to have been infected by it. Over that time, we’ve come to understand that, in most people, the virus causes mild symptoms or none at all -- at least at the time they have the virus. But even asymptomatic patients may suffer lingering effects. Jason Gale reports that it may contribute to the pandemic’s significant, long-term social and economic costs.
Aug 07, 2020
Will Kids Spread COVID to Teachers?
969
Earlier this year, school gates around the world slammed shut. The drastic measure worked in many places. Now, as fall approaches, attention is turning back to a pillar of a pandemic-resilient society: schools. The role of children in driving transmission of the coronavirus isn’t clear, and what we know about past respiratory infections isn’t a lot of help. But, as Bloomberg senior editor Jason Gale finds out, some clearer trends are emerging.
Aug 05, 2020
The Promise of a New Treatment
797
The drug company Eli Lilly is about to start testing its Covid-19 antibody drug in nursing homes. Vaccines may not work as well on elderly people or those with compromised immune systems. Since these are the very groups most at risk for severe disease or death if they contract the coronavirus, a successful antibody treatment could have a marked effect on lowering the pandemic’s death toll. Riley Griffin talks about the new drug, and the promise of antibody treatments.
Aug 03, 2020
What We Know About Immunity
764
In the race to study immunity to the virus, scientists first focused on antibodies -- proteins that stick to and disable foreign invaders. That’s because creating antibodies is the basis for most successful vaccines, so scientists are interested in learning who develops coronavirus antibodies, how long they stick around, and how effective they are at keeping people from getting infected again. But recent studies show there may be another weapon inside the human body that can rouse fresh antibody soldiers long after the first have left the battlefield. Bloomberg senior editor Jason Gale explains that T cells may be part of the key to blunting the coronavirus contagion.
Jul 31, 2020
The Data Disaster in the U.S.
838
More than a month into a resurgence of the novel coronavirus that has besieged Sun Belt states, flooded hospitals and strained public-health infrastructure, the U.S. still lacks a complete picture of the reality on the ground. That’s because the U.S. doesn’t have ANY real-time system to track the virus’s spread. At times, even the federal government has had to rely on third-party databases. Emma Court reports on the danger of a Covid-19 data black hole. 
Jul 29, 2020
Why a Vaccine Won't Create Instant Immunity
861
An effective vaccine is seen as the world’s greatest hope for achieving some kind of return to normal, and the timeline for developing one has been sped up dramatically. But as hard as it’s going to be to make a vaccine quickly, once we do, we’ll have a new problem: Getting it to billions of people. Brendan Murray explains how difficult it will be for the global supply chain to distribute and administer the drug.
Jul 27, 2020
Why The Crisis Hurts Maine's Lobster Industry
732
A few places in the U.S. are still relatively unscathed by the virus, but they haven’t been able to escape the economic devastation. Esme Duprez reports on why the fallout from Covid-19 is devastating Maine's lobster business.
Jul 24, 2020
The Campaign to Lure You Back to the Doctor
1020
When physicians and hospitals became overwhelmed with COVID-19 cases, other medical services, from routine tests to emergency room visits, fell dramatically. The long-term consequences of Americans putting off basic medical care may be disastrous. John Tozzi reports on a new push by the health-care industry to stop so-called "Medical Distancing.”
Jul 22, 2020
The Latin American Country That's Beating Covid
796
The small South American nation of Uruguay is best known for its grass-fed beef and Atlantic beaches. But the country of 3.5 million people has another distinction: It seems to have dodged the worst of the Covid-19 outbreak despite being nestled between hotspot countries. The country has seen just 1,000 or so cases since the pandemic began, and only 33 deaths. Ken Parks reports the reasons may have as much to do with its policies from years past, as its present day virus response.
Jul 20, 2020
The First Vaccine May Not Be the Best
860
An experimental Covid vaccine from Australia joined almost two dozen candidates in clinical trials this week. Development-wise, it’s months behind some of the frontrunners. Jason Gale explains that speed isn’t everything when it comes to fighting the pandemic.
Jul 17, 2020
Introducing: Blood River, A New Podcast From Bloomberg
268
The killers of Berta Caceres had every reason to believe they’d get away with murder. More than 100 other environmental activists in Honduras had been killed in the previous five years, yet almost no one had been punished for the crimes. Bloomberg’s Blood River follows a four-year quest to find her killers – a twisting trail that leads into the country’s circles of power. Blood River premieres on July 27.
Jul 16, 2020
The Story Behind the Six Foot Rule
888
While wearing a mask, or refusing to wear one, has become politicized, there’s one Covid safety measure we seem to be comparatively united about: Everyone knows they should stand six feet away from other people in public. But where did this guidance come from? Kristen V. Brown reports that one simple number is already changing our behavior, and will soon change the places where we live, work and play.
Jul 15, 2020
New Ways to Catch the Virus
1046
We’re learning more about how the virus that causes Covid-19 is spread from person to person. For the most part, it happens when we’re in close contact with an infected person, who emits tiny liquid particles by coughing, sneezing, speaking or singing. You get sick by inhaling the droplets, or having them travel into your ears or nose. But researchers are looking at another way it may be transmitted. Jason Gale reports that virus-laden aerosols, floating in gas clouds, might be capable of infecting us.
Jul 13, 2020
Excruciating Choices For Schools
936
With the start of school fast approaching, institutions from elementary schools to colleges are rushing to reinvent themselves for the coronavirus era. Some are shifting to a mix of in-person and virtual classes. Meanwhile, the Trump administration is pushing schools to reopen completely, regardless of safety. Emma Court reports that as schools become the latest political touchpoint in the Covid crisis, there are far more questions than answers about how to keep classrooms safe.
Jul 10, 2020
Virus Treatment Is Changing
863
In the almost 200 days since coronavirus cases were first reported in central China, health workers and researchers have raced to learn more about the brand new pathogen. As many as 1,000 Covid-19-related research papers are being released daily. Jason Gale reports that the research, and the experience of front-line health care workers, is informing better ways to diagnose, prevent and treat the disease. That’s helping to save lives.
Jul 08, 2020
Unemployed, Uninsured and Falling Through the Cracks
825
As a second Coronavirus wave threatens America, a wave of job losses since the disease first hit has left millions without health insurance. Reade Pickert explains that in other developed economies, the newly unemployed could rely on systems of universal health care. In America, they’ve had to navigate a bewildering menu of options to figure out if they have access to a patched-together safety net.
Jul 06, 2020
A Divided America Feeds the Crisis
960
The U.S. is home to the highest number of Covid-19 cases—2.6 million and counting—and the most deaths. The reasons for that are at least, in part, very American ones: Politicized science, a fragmented media landscape, and inequality. Executive Editor Brian Bremner reflects on how decades of political division have made the country a coronavirus superpower in the worst way--an outcome that was entirely avoidable. 
Jul 03, 2020
Why Deaths Seem to Drop as Cases Rise
940
Coronavirus continues its terrifying rampage of large swaths of the country. But the Trump administration has made a point of mentioning that even while cases are rising, deaths are declining. That disconnect is, he says, proof the Covid-19 pandemic is under control. But the mismatch could be an anomaly caused by quirks in how deaths data is collected and reported. It's not necessarily a sign the coronavirus is becoming less lethal or easier to treat. Robert Langreth and Emma Court report that it’s too soon to know for sure that deaths are still declining.
Jul 01, 2020
Learning to Love Big Pharma
912
Gilead Sciences announced today that it will charge the U.S. government and other developed countries $390 per vial for its coronavirus-fighting drug remdesivir. That begins to answer a big question as drug companies race to find treatments and develop vaccines for the virus: How much will it cost us? But Riley Griffin and Emma Court report that the Pharmaceutical industry is hoping Covid-19 will give it a chance to rebrand; and get the focus off drug prices.
Jun 29, 2020
Keeping Elderly Patients Safe
899
Around the world, nursing homes and assisted living facilities have been a hotbed for Covid-19 outbreaks. Because older people are particularly vulnerable, the facilities have had some of the deadliest outcomes during the pandemic. But some nursing homes have done much better than others at containing the virus. Angelica LaVito reports on a Seattle-area assisted living company that learned the lessons of the pandemic early, and has managed to keep outbreaks from raging out of control.
Jun 26, 2020
What Happened in Houston
922
In Houston, Texas, new Covid-19 cases and hospitalizations are surging. Some experts expect the virus outbreak to swamp the city’s medical infrastructure by July 4th. Emma Court and Joe Carroll report that if cases keep rising at their current pace in Harris County, which includes Houston, they will triple or quadruple by mid-July. The city’s hospital system may not be able to manage the crisis.
Jun 25, 2020
These Gadgets Know You're Sick Before You Do
872
The NBA is giving players the option to wear a device that tracks their health data when basketball games begin this July. The device - called an Oura Ring - can measure things like the body’s temperature and heart rate. The hope is that it could provide the league with early warning signs that someone may have contracted an illness like COVID-19. Bloomberg reporter Kristen V. Brown reports that the move is part of a larger conversation about whether or not wearable technology like a Fitbit or an Apple Watch can help fight the pandemic.
Jun 24, 2020
The Next Two Years of the Virus
915
More than six months into a shape-shifting pandemic that’s killed more than 454,000 people worldwide, it’s clear we are losing the battle against the outbreak. Most experts believe an effective vaccine won’t be ready until well into 2021. So how do we adjust our thinking from beating the virus, to coexisting with it? Michelle Fay Cortez discusses the next phase of the virus, and what public health professionals say we have to do to survive it.
Jun 23, 2020
History's Lessons for Our Post-Virus Future
1004
As soon as the Coronavirus became a pandemic, people began making parallels to the Spanish Flu outbreak of 1918, and reaching even further back to the black death of the middle ages. It makes sense--past pandemics may be our only reference point for whole populations being stricken with illness. But they can also tell us a lot about how economies recover after outbreaks. From the Odd Lots podcast, Tracy Alloway and Joe Weisenthal talk to Jamie Catherwood, an expert in finance history, about how Covid-19 is different -- and similar -- to decades-, and even centuries-old diseases.
Jun 22, 2020
How to Spot a Fake Mask
917
If there’s one simple technology that has come to the forefront during the coronavirus pandemic, it’s the face mask. Special masks called respirators are designed to prevent doctors and nurses from catching the virus when they treat infected people. But not all respirators do what they’re labelled to. Fakes and shoddy products abound. And you can’t always tell how many particles a mask can filter just by looking at it. Naomi Kresge reported on how you catch a fake mask – and the lengths one German company is going to, to fight the problem.
Jun 19, 2020
The New Superbug Threat
774
Long before the Covid pandemic, another global health disaster was brewing, threatening to kill millions of people annually. Superbugs – germs even our most potent antibiotics can’t defeat – pose a massive challenge to human health and wellbeing. The coronavirus, of course, isn’t stopped by antibiotics, which target bacteria. Even so, antibiotics have been used liberally for Covid-19 patients. Jason Gale reports that could worsen the superbug crisis.
Jun 18, 2020
Should You Take an Antibody Test?
893
It’s now relatively easy to get tested to see if you carry the antibodies for Covid-19. Urgent Care centers and many doctor’s offices are offering the tests widely. But the science is still out on whether or not people who have had Covid-19 become immune to it. Not to mention the possibility that the test you take may not be accurate. Reporter Kristen V. Brown tries to answer the question: is it worth taking the test at all?
Jun 17, 2020
The Virus Explodes in Latin America
824
As the pandemic spreads around the world, new hotspots are emerging. Coronavirus is spiking in Brazil, Mexico, Peru and elsewhere, and health experts have called Latin America the new epicenter of the pandemic. But the impact has been uneven. Some countries have successfully slowed the rate of new infections; others see that rate continuing to climb. Jason Gale spoke with the World Health Organization’s top official for the Americas to find out what makes some populations especially vulnerable.
Jun 16, 2020
Welcome to the Second Wave
982
Covid-19 is on the rise around the country. Texas and Florida, two of the most populous U.S. states, reported record numbers of new infections on Sunday. The recent surge in those states and others has led public-health officials to worry that reopening the economy has come at too grave a cost. What's clear is that between reopening policies, weariness with staying home, and large protests around the country, Americans are moving around and interacting more than they have in months. Emma Court has been covering what is increasingly looking like a second wave of the virus.
Jun 15, 2020
The Effect of Quarantine on Kids
717
When the country went into lockdown this spring, it forced kids to adapt to a new life at home. The adjustment for them--and their parents -- has been huge. Experts still aren’t sure what will happen in the upcoming school year, meaning kids could be living in quarantine for much longer. Kristen V. Brown reports on what we how children are coping with the virus so far.
Jun 12, 2020
The New Threat to Mexico's Failing Hospitals
930
The coronavirus is hitting Latin America in ways unseen in the developed world. In Mexico, Covid-19 is savaging a health care system that was already inadequate. Doctors and nurses in Mexico say they lack masks and gloves. Hospitals are at 80% capacity in Mexico City. More than 20,000 health care workers have caught the virus. Nacha Cattan reports on what happens when a crisis hits a system that was unprepared, and underfunded, in the best of times.
Jun 11, 2020
Understanding Silent Spreaders
791
A top World Health Organization official sparked a controversy earlier this week when she said cases of asymptomatic carriers of COVID-19 spreading the virus are "very rare.” She later clarified her remarks. That provided a moment to explore the debate over so-called silent spreaders -- people who don't get sick after they're infected with the virus -- and their role in its transmission.
Jun 10, 2020
Why COVID-19 Lingers
869
Never in the modern scientific era have so many people been infected with the same virus in such a short period of time. For many survivors of coronavirus, symptoms hang on for weeks or even months. Bloomberg senior editor Jason Gale reports on efforts for finding ways to prevent such cases of post-Covid-19 illness in the future.
Jun 09, 2020
The Truth About Hydroxychloroquine
934
The controversial drug is back in the news. In the early days of the pandemic, President Trump and some doctors touted it as an effective treatment. But studies soon discredited the treatment. Now, in an unexpected twist, some research papers dismissing the drug have also been thrown in doubt. So how useful is Hydroxychloroquine and how reliable are the reviews we rely on to assess a drug's safety? Laura Carlson speaks to Bloomberg reporters Michelle Cortez and Robert Langreth for answers.
Jun 08, 2020
Madrid's Bittersweet Spring
944
Madrid was one of Europe’s hardest hit cities by the coronavirus, but now it's coming back to life. We explore how the reopening is going as Bloomberg reporter Jeannette Neumann talks to owners of some of the hundreds of bars, restaurants, and hotels that dot the city.
Jun 05, 2020
Will Protests Spread The Virus?
862
Social distancing has been the guiding principle in how to open up the U.S. amid the pandemic. But no one could have foreseen the densely-packed protests after George Floyd’s death in police custody. Could the protests now set off a new wave of infections? Bloomberg’s Michelle Cortez spoke to scientists about that possibility. What they have to say is not reassuring.
Jun 04, 2020
Will Anyone Be Able to Afford Covid Drugs?
971
Senate Finance Committee Chairman Chuck Grassley insists that the long-delayed drug-price bill he is co-sponsoring will get a vote this year. Grassley worries that if the bill doesn't pass, drugmakers will charge whatever they want for Covid-19 related drugs. But drug lobbyists are counting on the coronavirus making drug pricing reform obsolete. Emma Court and Riley Griffin spoke to Senator Grassley about the bill.
Jun 03, 2020
Why New York Got Hit So Hard
828
At least 21,000 New Yorkers are dead from Covid-19, with a few dozen added to the city’s count every day. The city’s deaths are 10 times those of Los Angeles County’s. They’ve surpassed the 16,000 lives lost in Italy’s hard-hit Lombardy region. Drew Armstrong reviewed the statements of experts, officials, and politicians to better understand the root causes of New York City’s devastating outbreak.
Jun 02, 2020
A Canine Virus Detection System
787
Dogs have long had a positive slink with human health. Science has shown that the benefits of dog ownership extend from reducing the risk of schizophrenia to improving cardiovascular health. But Jason Gale reports they may have other, untapped powers to help stop the spread of coronavirus. Plus: How coronavirus created the conditions for the recent nationwide protests.
Jun 01, 2020
What Heat Really Does to the Virus
766
Scientists and politicians have wondered for months whether the coronavirus would diminish, if not disappear entirely, over the summer. As the weather heats up in the Northern Hemisphere, and cools down in the Southern part of the world Jason Gale talked to one of America’s most respected public health experts to understand the facts about the virus in warm weather.
May 29, 2020
A New Vaccine Frontrunner
874
As competitors publicly entered the race to produce a vaccine, drug giant Merck stayed quiet about its development plans. Now, the company has revealed it’s working on two vaccines and a treatment pill -- emerging as a frontrunner in the development contest. Although the company has refused to give firm timelines for its research, it has pledged to make its vaccines and pill available globally, if they're successful. Riley Griffin talked with Merck Chief Executive Kenneth C. Frazier about the company's plans.
May 28, 2020
How Many People Have Really Died?
920
So far, more than 300,000 people globally are known to have died because of the coronavirus. The U.S. is fast approaching the grim milestone of 100,000 fatalities. And as shocking as those numbers are, experts believe there are actually many more deaths we’re not counting. We need to understand how fast, and in what groups, mortality is rising, in order to fine-tune the policies that govern our response to the virus. Jason Gale reports that experts are looking past the official count to find other ways to investigate just how many people are dying.
May 27, 2020
Virus Hunting With the 'Pirate CDC'
1008
Knowing how many people are being tested for coronavirus is essential for getting an accurate picture of the spread of the virus. But the government hasn’t readily provided this data. Instead, experts, media outlets and even the Trump administration have turned to a surprising source for these numbers: A volunteer effort by a team of journalists, called the Covid Tracking Project. Emma Court reports on what we're learning from the project.
May 26, 2020
The Home Run Approach
690
There's an innovative, but risky way we could speed up development of a COVID-19 vaccine. Some scientists argue we should intentionally infect volunteers with the coronavirus to get a vaccine sooner. How would it work? Today's special episode is a collaboration with Tradeoffs, a podcast about our costly, complicated and counter-intuitive health care system. Tradeoffs' Dan Gorenstein explores how scientists could ethically and safely infect people to speed up the fight against COVID-19. Subscribe to the Tradeoffs podcast on Apple Podcasts, Spotify, or wherever you listen. Or check them out at tradeoffs.org.
May 25, 2020
Curing Social Distance Fatigue
865
There’s a growing public health argument about how people should calculate risk when it comes to social distancing. Many states are now lifting stay-at-home restrictions, summer is around the corner, and people in the third month of what many hoped would be a weeks-long disruption are desperate to visit friends and get outside. That means we will be socializing a lot more--in many cases, without clear guidelines as to what’s really risky. Kristen V. Brown reports that as we learn more about how the virus spreads, and what constitutes risky behavior, messaging from experts will have to become a little more nuanced than just “stay home, stay safe.”
May 22, 2020
The Dire Situation at U.S. Prisons
1087
Calls continue to mount for the release of inmates at risk of COVID-19 infection as cases rise at correctional facilities across the country. So far, 70 percent of inmates have tested positive for the coronavirus, according to the Bureau of Prisons. Oakdale Federal Correctional Complex, a low-security prison about 200 miles west of New Orleans, is one of the federal prisons hardest hit by the coronavirus pandemic. Jordan Gass-Poore’ reports on what is being done to combat the spread of the disease in the prison population.
May 21, 2020
The Rise of Vaccine Nationalism
889
Covid-19 has sparked an unprecedented mobilization of researchers looking to create a drug that can stem the spread of the virus. Globally, drug developers are working on as many as 100 experimental vaccines. But as nations rush to ease lockdowns and restart economies, some countries seem to want to secure early supplies of a vaccine for themselves. James Paton reported on efforts to democratize international access to vaccines, and the dangers of creating immunization gaps.
May 20, 2020
The True Origins of the Virus
933
The Internet has been teeming with theories about the origin of the coronavirus. Scientists have been saying for more than three months that it most likely originated in a species of bat found in the south of China, and then managed to somehow jump into people. But alternative explanations have been floated. United States Secretary of State Mike Pompeo has repeatedly blamed China, and specifically a laboratory in Wuhan that was researching dangerous viruses. Jason Gale talked to a World Health Organization scientist to tease out the most plausible explanation for where the virus came from.
May 19, 2020
The Virus Trackers
918
The tedious and time-consuming practice of contact tracing is seen as an essential ingredient for suppressing the coronavirus around the world; but not every country has invested in it. The World Health Organization has praised Germany for its contact tracing practices. The country has about a quarter the deaths of neighboring France, despite a more flexible lockdown. Last weekend it continued its cautious move toward pandemic normalcy by letting restaurants re-open. Naomi Kresge reports on the Würzburg region, where armies of tracers are fighting the virus with old-fashioned tools.
May 18, 2020
Can The Aviation Industry Afford To Keep You Safe?
936
The aviation industry is wrestling with ways to control the coronavirus and get people back to flying. Airports have seen a 90 percent drop in passengers since mid-March. But as states ease lockdown restrictions, more people are expected to fly. Airports today are starting to make changes in the hopes that passengers will be safer as they fly. Justin Bachman reports on what it looks like to fly during a pandemic, and how air travel may change going forward.
May 15, 2020
This Drug Maker Saw the Pandemic Coming
915
When Covid-19 hit, Gilead Sciences Inc. had enough of its experimental drug remdesivir ready to test and start manufacturing it at a larger scale. That's because it had started stockpiling not just the drug, but its ingredients, at the first hint there may be a new coronavirus. Robert Langreth reports on why the company was able to act early to prepare for a pandemic when so many businesses and institutions did not.
May 14, 2020
The Scary Implications of 'Covid Toe'
787
As Covid-19 infects more and more people, doctors around are learning that the coronavirus doesn’t just attack the lungs. The virus can cause kidney failure; send the body’s immune system into high gear; and lead to a range of clotting-related disorders. Jason Gale reports on how much more we have yet to learn about what the virus does to the body.
May 13, 2020
Your Quarantine Questions, Answered
1070
After months of sheltering in place, some people have begun looking for ways to get around some of the more onerous social distancing guidelines. That’s especially true as the weather warms up in the U.S. Bloomberg reporter Kristen V. Brown collected listener questions around social distancing etiquette, and brought them to an expert to clear up the confusion. If you have any more quarantine questions, give us a call at 646 324 3490. We may even play your voicemail on a future show.
May 12, 2020
New Fears About Kids Getting Sick
953
Last week, a five-year-old boy in New York died from Covid-19-related complications. Dozens of other children are becoming sick with a similar cluster of symptoms that mirror a rare condition called Kawasaki disease. The accepted wisdom had been that children could transmit the virus, but not get sick from it. The new illness is throwing that assumption into question. Jason Gale talked to the world’s leading expert on Kawasaki disease to help unpack what is going on.
May 11, 2020
Is the Virus Getting Worse?
861
Last week, researchers at the Los Alamos National Laboratory released alarming news: At least one variant of the virus that causes Covid-19 had significantly mutated to become more contagious. If true, this would have major implications. A new variant could, for example, hamper efforts to develop a vaccine or mean that people who’ve already had Covid-19 might face a greater risk of getting it again. But critics said the data didn’t support such a big claim. Kristen V. Brown discusses what it really means that the virus is changing.
May 08, 2020
The Problem With Antibody Tests
775
Antibody tests are suddenly everywhere. These tests are designed to determine whether someone contracted the virus in the past. They help policy makers understand how the virus spreads, and whether measures to contain the virus are working. Federal regulators relaxed guidelines to make it easier for companies to produce the tests, but this has allowed for a flood of unreliable--and sometimes fraudulent--tests to be offered to consumers. Now, Kristen V. Brown reports, the government is trying to control the mess.
May 07, 2020
Inside a Vaccine Clinical Trial
886
Dozens of research teams across the world are racing to deliver a vaccine for the coronavirus. Developing, testing and bringing a vaccine to market is a process that usually takes years, even decades. But that process is being ramped up to warp speed as the virus ravages the globe. A small group of volunteers is already receiving an experimental vaccine. Jason Gale spoke to one of them, and gives us a peek inside the fast-moving world of coronavirus vaccine development.
May 06, 2020
We May Never Have A Vaccine
1066
Doctor Richard Besser was the acting director of the Centers for Disease Control and Prevention in 2009, when the H1N1 Swine flu pandemic broke out. The physician-turned-epidemiologist now runs the Robert Wood Johnson foundation with a mission to improve health equality. Reporter Riley Griffin spoke to him about what happens to the most vulnerable communities as states begin to relax social distancing rules; and the danger that we'll never have a vaccine.
May 05, 2020
Fraying Mental Health on the Front Lines
785
Health-care workers are under threat from more than just the coronavirus itself: The mental health effects of the work are grave. Doctors and nurses fighting Covid-19 are watching patients die at rates rarely seen in civilian medicine; and they’re delivering the news to family members who aren’t allowed inside the hospital for fear of spreading the disease. Hospitals are trying to treat the minds and hearts of the healers by offering counseling, crisis hotlines and therapy dogs. Emma Court discusses the scars the pandemic is leaving on hospital workers, and what the health care system can do about it.
May 04, 2020
The Dangers of Superfast Science
1106
Scientists are facing unparalleled pressure to provide information about the coronavirus as quickly as possible. And when every day brings forth new data, what was clear one day may be confusing the next. Guidance has shifted rapidly about the benefits of wearing masks, how the virus spreads, and even the efficacy of promising new drugs like Remdesivir. Science doesn't usually move this fast. Michelle Fay Cortez and Robert Langreth report on what happens when the slow and steady process of research, peer review, and the traditional publication process hits warp speed?
May 01, 2020
What Puts Patients at Risk
885
As Covid-19 spreads, doctors are learning more about why some patients get very sick, and why others only get mildly ill. Some of the people most at risk for severe illness have underlying conditions that affect their lungs. Older people are also at a higher risk. But certain factors, when combined with age, create a powder keg for the effects of the disease. Both smoking and obesity are conditions that can lead to fatal results in Covid-19 patients. Bloomberg Senior Editor Jason Gale explains how these conditions have made the coronavirus more lethal in some countries.
Apr 30, 2020
Who's Really Immune?
798
As states grapple with the question of when it will be safe to reopen businesses and relax social distancing, there's increasing urgency to better understand who's immune to Covid-19. Does having the virus and recovering mean you can't get it again, or at least that you can’t be reinfected for some time? No one yet has good answers to these questions. Kristen V. Brown looked into what we do, and don't, know about the science of coronavirus immunity.
Apr 29, 2020
The Problem With Trump's Testing Plan
995
The Trump administration announced a plan yesterday to ramp up coronavirus testing. But even as it announces this new push, the Federal government has pushed much of the responsibility for testing to states. Experts say the lack of Federal leadership has led to a free-for-all, where states compete to get their hands on tests, and few states are left in a good position to reopen. Emma Court and John Tozzi report on the difficult logistics required to mount a meaningful testing operation.
Apr 28, 2020
All Eyes on Iceland
1030
Iceland has become one of the best places in the world to study Covid-19. That’s because the country is an island nation with only one real port of entry and a small population. It also introduced widespread testing as soon as the virus arrived in March. Bloomberg reporter Kristen V. Brown traveled to Reykjavik, the capital, just as the global scale of the pandemic was starting to become clear. She reports that the rest of the world is learning from Iceland about how the virus moves through a population.
Apr 27, 2020
Life Can Be Hell After a Ventilator
949
Ventilators have become prized in hospitals across the U.S. and beyond because they are desperately needed to treat very ill Covid-19 patients. But they are also feared for the damage they can inflict, and for the slim odds of survival they offer. Michelle Fay Cortez and Olivia Carville report that it's not yet clear what the long-term consequences ventilators have for those lucky enough to recover after having been on one.
Apr 24, 2020
Life After Lockdown in Wuhan
819
Millions in Wuhan, China, the city where the novel coronavirus first emerged, are trying to figure out what life looks like in the bustling industrial city after the worst pandemic in a century. Bloomberg’s Beijing bureau chief Sharon Chen went to Wuhan recently to explore life after lockdown. She found a world that still feels far from normal, and a population that’s keenly aware of both the threat of disease, and the watchful eye of China’s surveillance state.
Apr 23, 2020
The Patients Left Behind
895
The pandemic is putting care on hold for a lot of people with other serious health conditions, like cancer. Doctors are delaying procedures and surgeries in order to save resources like hospital beds and ventilators for Covid-19 patients, and prevent the infection from spreading. Emma Court reports on the difficult choices doctors are forced to make, and the danger that we're creating another health care crisis.
Apr 22, 2020
Inside China's Chaotic Mask Market
1028
The shortages of protective masks that keep healthcare workers safe from Covid-19 are well documented by now. To meet the need, U.S. hospitals have taken the extreme step of turning directly to Chinese manufacturers. Reporter Riley Griffin reports that the demand has helped spur a Wild West scenario, where Profiteering middlemen ratchet up prices. Buyers must sometimes go to extraordinary lengths to try to ensure quality.
Apr 21, 2020
The Other Epidemic
786
Before COVID-19 started spreading around the U.S., the country was already attempting to deal with another health crisis: opioid dependency. Although opioid-treatment programs are considered essential public facilities and are allowed to stay open during statewide stay-at-home orders, experts are worried the coronavirus could exacerbate the opioid epidemic, possibly leading to more overdoses.
Apr 20, 2020
A Cure in Survivors' Blood?
743
There’s a sliver of hope for people very ill with Covid-19. It’s a bold new treatment that involves taking the blood plasma of people who have recovered from the disease, and injecting it into people who are very sick.  The secret is in the antibodies: a protein that is produced when someone’s immune system has fought the virus. But using antibodies to treat the sick is more complicated than just transferring them from one person to another. Jason Gale reports on what researchers are doing to sift through the many antibodies out there, and find the right ones to help people recover from being infected.
Apr 17, 2020
The One-Two Punch to Black America
668
As data about the health outcomes of the new coronavirus come in, it's clear that black people are dying at disproportionate rates to their percentage of the population. But a new report shows it’s not just black Americans’ health that will suffer. The virus will likely have a devastating effect on their jobs and future earnings. Donald Moore talked to researchers about the economic and physical traps the virus is setting for the demographic.
Apr 16, 2020
A Covid Early Warning Sign
821
Losing the ability to smell is one of the strangest clues that someone may have COVID-19. Experts around the world are still trying to understand why this symptom pops up, and what it means for patients. Some are calling on people who have lost their sense of smell to get tested and isolate themselves, even if they have no other symptoms. Jason Gale reports that the symptom could be an early warning sign--and screening for it could help contain the virus.6
Apr 15, 2020
Apple and Amazon vs. the Virus
812
Two of the worlds biggest companies, Apple and Amazon, rely on a supply chain that is spread all across the world, in many countries that have been hardest hit by the coronavirus. The tech giants employ hundreds of thousands of people so their fate, in many ways, is the fate of the global economy. Brad Stone, Bloomberg's head of global technology coverage, reports.
Apr 14, 2020
What Happened to the CDC?
942
Historically, the U.S. Centers for Disease control and Prevention has been the agency in charge of predicting, and containing outbreaks of disease. But as Covid 19 ravaged the country, the agency took a backseat to the White House. Michelle Fay Cortez and John Tozzi discuss how the agency has handled the pandemic response, its early missteps, and how its role is likely to change in the future.
Apr 13, 2020
How It All Started
1432
On a special episode of Prognosis Daily, we’re taking a close look at how the novel coronavirus lived before it entered humans and who it lived in. Bats. They’re almost certainly the source of this pandemic, but these flying mammals may also hold the clues to stopping the next one. Bloomberg senior editor Jason Gale explores how research into bats led to the discovery of what could be the precursor of the novel coronavirus. This vital research is also laying the groundwork for potential treatments.
Apr 10, 2020
Hunting For the Virus in Sewage
749
Scientists are desperate for a way to detect the novel coronavirus in communities as early as possible. So far, those efforts have focused on widespread testing of people. But a group of Dutch researchers may have discovered a way to tell where the virus is spreading, right beneath their feet. Jason Gale looks at the people hunting for early-warning signs in sewage.
Apr 09, 2020
A Mental Health Crisis Worsens
828
The effects of the outbreak are putting unprecedented stress on thousands of people. But the difficulty of obtaining mental health services while under lockdown threatens to break a treatment network that was already strained to the breaking point. Cynthia Koons explains how companies are trying to meet that demand and how the crisis may change the way we receive mental health care.
Apr 08, 2020
How to Wear a Mask
793
The U.S. Centers for Disease Control and Prevention recently changed their guidelines on whether healthy people should wear masks, suggesting that people cover their faces to help slow transmission of the novel coronavirus. The evolving view on face masks is just one more example of how quickly our understanding of the virus is changing. It also makes it hard for the public to know what information to take seriously. James Paton reports on what masks really do, why some still warn against their use, and how many people might be wearing them wrong.
Apr 07, 2020
This is How We End It
930
With Covid 19 crippling much of the world, there’s intense uncertainty about what’s next. In the United States, it’s hard to envision when the economy, and our lives, will get back to normal. But it turns out there is a plan to beat the virus, and to get the country back to work. The question is whether the government will follow it. Health reporter Anna Edney spoke to Scott Gottlieb, a former Food and Drug Administration commissioner and current informal adviser to the White House, about what happens in the coming months, and years.
Apr 06, 2020
What Germany Did Right
926
Italy has been among the hardest hit countries by coronavirus. An outbreak epicenter, Italy’s cases are at nearly 120,000 with over 14,000 deaths. It’s sobering evidence of how vicious the virus can be. And yet, just to the north, Germany seemed like it was escaping the worst of the outbreak by enacting widespread testing and taking the virus seriously earlier. With fewer cases and, until recently, a mortality rate that hovered under 1%, Germany appeared to be a model of how to successfully navigate the crisis. But now there’s some doubt about whether Germany is really a Covid-19 success story. Naomi Kresge reports.
Apr 03, 2020
The Case For Writing Every American a Check
786
Under the $2 Trillion economic stimulus bill passed last week, the US government will make direct payments to Americans who are suffering because of the coronavirus pandemic. Giving everybody money, with no strings attached, has an obvious benefit in an economic emergency. But some economists have always advocated for handing out money to nearly everyone, in good times and bad. Joe Weisenthal explains. Plus the day's Covid-19 headlines.
Apr 02, 2020
When Will We Have a Vaccine?
985
Scientists around the world are racing to develop a vaccine for COVID-19. But experts have said it could take a year to 18 months for one to hit the market. The process for testing and approving a vaccine is long and complicated. That can be frustrating when the coronavirus is taking more and more lives every day. But cutting corners to push a vaccine through faster can lead to devastating consequences. We know that, because it’s happened before.
Apr 01, 2020
When You Can't Go See the Doctor
921
Around the country and the world, more and more people are locked down in their homes, but people still need to see the doctor. That has made telehealth companies -- businesses that let doctors treat patients remotely -- the new stars of the Covid-19 economy. And companies that until now have mainly offered prescriptions for birth control or hair loss pills are pivoting
Mar 31, 2020
This is How the Virus Kills
972
Covid-19 acts in a way that scientists are still trying to figure out. In some people who are infected, symptoms are mild -- like a common cold. Some are completely fine. In others, the infection can be fatal, stopping the lungs from functioning and causing the body to shut down. So why are symptoms so mild in some people and deadly in others? It turns out there's a tipping point -- a moment where the virus moves from one part of the body to another -- that takes the infection from manageable to fatal.
Mar 30, 2020
Prognosis Daily: The Coronavirus Detectives
787
A little known geneticist in Seattle has become something of a CSI detective, unraveling the origins of Covid 19 in the U S. Could his research hold secrets to a better understanding of the disease? Some policymakers seem to think so. Plus: today's headlines.
Mar 27, 2020
Special Episode: Understanding Pandemics
1842
How can we make sense of the scary reality we are all now living in? Where do pandemics come from? And why are they occurring more frequently? On this special episode, Bloomberg’s Jason Gale talks to some of the world’s most experienced pandemic experts to get their insights.
Mar 26, 2020
Prognosis Daily: What Went Wrong With Testing
843
On the series premiere of the Prognosis daily podcast, host Laura Carlson gives the latest updates on the coronavirus outbreak. Health officials around the world have been urging countries to conduct widespread testing. Jason Gale explores why some nations have been slow to respond.
Mar 26, 2020
Announcing Prognosis Daily: Coronavirus
100
Harnessing Bloomberg's reporting from every continent, Bloomberg's daily Prognosis podcast brings the news, data and analysis you need for living in the time of Covid-19. In around ten minutes, we will explain the latest developments in health and science, the impact on individuals, industries and governments and the adaptions they are making in the face of the global pandemic. Come back every weekday afternoon for a short dose of the best information about the novel coronavirus from more than 120 bureaus around the world. First episode drops Thursday, March 26.
Mar 24, 2020
Introducing Deep Background with Noah Feldman: Civil Liberties in the Time of COVID-19
2252
From Pushkin Industries, introducing Deep Background with Noah Feldman. Every story has a backstory, even in today's 24-hour news cycle. In Deep Background, Harvard Law School professor and Bloomberg Opinions columnist Noah Feldman will bring together a cross-section of expert guests to explore the historical, scientific, legal, and cultural context that help us understand what's really going on behind the biggest stories in the news. This week, Richard Lazarus, a law professor at Harvard and a leading Supreme Court advocate, discusses where public health stops and our individual liberties begin. Plus, what does it mean that the Supreme Court has postponed oral arguments? Learn more and subscribe to Deep Background on Apple Podcasts, Spotify, or wherever you listen.
Mar 17, 2020
Superbugs' Natural Predator (Rebroadcast)
1673
We continue our look back at some of our favorite episodes from the podcast. Joel Grimwood was almost certainly going to die. The pump that kept his failing heart going had become infected, and surgery after surgery had scraped away parts of his chest. Drugs didn’t work because the bacteria were in a slime, impenetrable to antibiotics. What saved his life was a little-known treatment called phage therapy. Popular in the former Soviet Union, they’ve fallen out of favor in the West. The viruses are the natural predator of bacteria, and a small number of scientists are trying to turn them against the threat.
Feb 27, 2020
Superbugs Force a Deadly Choice for Cancer Patients (Rebroadcast)
2019
We continue our look back at some of our favorite episodes from the podcast. Among those most vulnerable to superbug infections are cancer chemotherapy patients. In India, many are dying from bacteria poisoning their blood that even the most potent antibiotics available can't stop. This calamitous scenario portends a global crisis as superbugs spread through international travel and trade.
Feb 20, 2020
The Skinny on Diet and Health Apps (Rebroadcast)
1401
We continue our look back at some of our favorite episodes from the podcast. Do exercise-tracking apps and gadgets like the Fitbit actually make us healthier? Or do they just create a high-tech, data-centric illusion of control over our weight, sleep and general well-being? Bloomberg's Naomi Kresge loaded up some popular apps to find the answer –- and to see if she could get a better night’s sleep than her husband.
Feb 13, 2020
Engineering Your Own Pancreas (Rebroadcast)
1603
We're revisiting some of our favorite episodes, starting with our very first. More than a million Americans suffer from Type 1 diabetes. The disease occurs when the pancreas mysteriously stops producing insulin, the hormone that converts food into energy. Modern medicine has been able to recreate insulin, but not the finely calibrated delivery mechanism of the pancreas. Now a group of like-minded do-it-yourselfers have gotten together on the internet and—working outside the purview of organized medicine—have figured out how to link a pump, glucose monitor and smartphone to simulate a functioning pancreas. The results have been spectacularly successful.
Feb 06, 2020
How to Buy a Better Birth
1570
The average cost of having a baby in the United States is $11,000 for people on private health insurance. But the price tag can vary by tens of thousands of dollars, depending on what hospital you go to and what doctor you see. And high-price medical care isn’t necessarily better: In the U.S., regardless of how much they or their insurance company pays, women experience unexpected problems related to pregnancy and childbirth at alarming rates. The problem, of course, isn’t limited to maternity costs. Across the health-care system, wide differences in price and quality for the same procedures have led many economists and policymakers to conclude that the marketplace for medical care is broken. This week on Prognosis, we look at one health plan’s attempt to make it work better. It’s pushing hospitals to improve maternity care while keeping costs in check. These efforts bring to light a lot about what’s wrong with American health care, and one ambitious attempt to fix it.
Jan 30, 2020
Fixing Health Care for the People It Often Fails
1414
In America, poverty is linked to shorter lifespans. The wealthiest 1% of Americans live more than a decade longer than the poorest 1%, and the longevity gap has expanded in recent years. The medical community is increasingly examining the role that poverty and difficult social circumstances play in illness. Some people are asking whether the health care system could do more to address the things that influence people’s health beyond their medical care. This week on Prognosis, we look at one startup that’s trying to redesign care for some of the most vulnerable patients, taking into account the complex realities of their lives. The company is trying to improve care for people and communities the medical system often fails – and it believes that fixing those failures will not only make people healthier, it will also save money.
Jan 23, 2020
The Doctor, the Patient, and Everything in Between
1539
Independent doctors are a vanishing breed. Hospitals have spent decades scooping up physician groups to build large, powerful health-care systems. The rationale was to increase efficiency and save money but often the opposite occurred. In fact, lots of evidence shows that consolidation in health care has driven prices higher. And both physicians and patients increasingly feel that big health systems and insurance companies have too much sway over what happens in the exam room. A few years ago, a group of doctors in Charlotte, North Carolina, decided they’d had enough. They split from the big hospital system that owned their practice to strike out on their own. They’re betting that they can be more competitive, and serve their patients better, independent of their former owners. In this episode of Prognosis, we tell the story of how one doctors’ group bucked the trend toward more concentrated health-care markets, and what it might mean for the future of the U.S. health-care system.
Jan 16, 2020
How U.S. Health Care Broke The Bank
1462
In 2020, Americans will spend almost $4 trillion on health care. Yet for all that spending, Americans overall tend to be less healthy and die younger than citizens of other wealthy nations. The cost of health care has become so burdensome that people all across the United States are forced to make difficult choices every day: forgo urgently needed medicines or treatment for serious injuries out of fear the cost, even with insurance, could bankrupt them. How did the U.S. health-care system get this way? And what are some people trying to do to change it? This season’s Prognosis explores these questions. 
Jan 09, 2020
Introducing Prognosis Season 4: America's Broken Health-Care Costs
135
Americans are paying more and getting less for their health care than ever before. On the new season of Prognosis, reporter John Tozzi explores what went wrong. 
Jan 08, 2020
Coming Soon: Travel Genius Season 2
129
Bloomberg's Travel Genius podcast is back! After clocking another hundred-thousand miles in the sky, hosts Nikki Ekstein and Mark Ellwood have a whole new series of flight hacking, restaurant sleuthing, and hotel booking tips to inspire your own getaways—along with a who's who roster of itinerant pros ready to spill their own travel secrets. From a special episode on Disney to a master class on packing, we'll go high, low, east, west, and everywhere in between. The new season starts Nov. 6.
Oct 29, 2019
Introducing Stephanomics Season 2
188
Stephanie Flanders, head of Bloomberg Economics, returns to bring you another season of on-the-ground insight into the forces driving global growth and jobs today. From the cosmetics maker in California grappling with Donald Trump's tariff war, to the coffee vendor in Argentina burdened by the nation's never-ending crises, Bloomberg's 130-plus economic reporters and economists around the world head into the field to tell these stories. Stephanomics will also look hard at the solutions, in the lead-up to Bloomberg’s second New Economy Forum in Beijing, where a select group of business leaders, politicians and thinkers will gather to chart a better course on trade, global governance, climate and more. Stephanomics will help lead the way for those debates not just with Bloomberg journalists but also discussion and analysis from world-renowned experts into the forces that are moving markets and reshaping the world. The new season of Stephanomics launches Oct. 3.
Oct 02, 2019
Fighting Back Against Killer Superbugs
1762
Many antibiotic pills we’ve relied on for decades to treat infections no longer work. It’s a global crisis. Hospitals are increasingly stumped. But where do resistant bugs come from?
 
 In our final episode of this season’s Prognosis, Bloomberg Senior Editor Jason Gale takes us to Copenhagen, Denmark, where one scientist searches for clues in airplane waste from all over the globe. He found killer superbugs thriving in healthy people from countries far and wide. Even in countries where antibiotic use has been strictly controlled, resistant bacteria have made their way to people via the food chain. Yet it’s not too late to turn back 


Sep 26, 2019
The Mystery That Makes Hospitals Sick
1362
It's no secret that dangerous superbugs are showing up more and more in hospitals around the world. But where do they come? How do they get into hospitals in the first place? In this episode of Prognosis, Bloomberg's Jason Gale unravels the mystery, taking us on a detective's search for the world's most deadly superbugs as they stealthily sneak into hospitals. And how one hospital has come up with a simple yet virtually foolproof safeguard against spreading those bugs once inside the building. The implications are huge for how hospitals around the world fight back against the spread of killer germs.
Sep 19, 2019
Superbugs' Natural Predator
1649
Joel Grimwood was almost certainly going to die. The pump that kept his failing heart going had become infected, and surgery after surgery had scraped away parts of his chest. Drugs didn’t work because the bacteria were in a slime, impenetrable to antibiotics. What saved his life was a little-known treatment called phage therapy. Popular in the former Soviet Union, they’ve fallen out of favor in the West. The viruses are the natural predator of bacteria, and a small number of scientists are trying to turn them against the threat.
Sep 12, 2019
Superbugs Force a Deadly Choice for Cancer Patients
2000
Among those most vulnerable to superbug infections are cancer chemotherapy patients. In India, many are dying from bacteria poisoning their blood that even the most potent antibiotics available can't stop. This calamitous scenario portends a global crisis as superbugs to spread through international travel and trade.
Sep 05, 2019
Introducing Prognosis Season 3: Superbugs
208
On this new season of Prognosis, we look at the spread of infections that are resistant to antimicrobial medicines. You're probably more likely to have heard of these as superbugs. Their rise has been described as a silent tsunami of catastrophic proportions. We travel to countries on the frontline of the crisis, and explore how hospitals and doctors around the world are fighting back. Prognosis’ new season launches Sept. 5.
Aug 26, 2019
Why China Loves DNA Tests for Babies
1828
Chinese consumers, just like Westerners, are lining up for DNA tests. But unlike their American and European counterparts, the Chinese appear to have far fewer qualms about privacy and sharing their data. And what they’re expecting to glean from their genetic information goes far beyond family trees or hints of future disease. From assessing the talents of hours-old infants to making career and life decisions based on DNA tests, the Chinese have fully embraced the genetics boom. 
Jul 04, 2019
The Skinny on Diet and Health Apps
1386
Do exercise-tracking apps and gadgets like the Fitbit actually make us healthier? Or do they just create a high-tech, data-centric illusion of control over our weight, sleep and general well-being? Bloomberg's Naomi Kresge loaded up some popular apps to find the answer –- and to see if she could get a better night’s sleep than her husband.
Jun 20, 2019
“I’ve Given Up on the Idea of Privacy”
1812
By now most of us understand the privacy consequences of all the data we handed over to social media and Internet companies. But what happens to the huge amount of health information we generate from health apps, DNA kits, doctors' visits, blood tests and fitness trackers? Some of it's carefully protected by law. Other data -- including intimate details about our lives -- can be sold to brokers who trade it like a commodity. How worried should we be?
Jun 06, 2019
Gift Cards for Your DNA Data
1416
On our latest episode of Prognosis, reporter Kristen V. Brown sells her DNA data to the highest bidder. Health data has turned into big business, but Brown quickly realized she wasn’t about to get rich. In exchange for an Amazon gift card or a few shares of marginal value, companies promise to use your data in the quest for better healthcare. 
May 23, 2019
Should We Be Scared of Our DNA?
1520
On this episode of Prognosis, reporter Michelle Fay Cortez probes one of the more disturbing unintended consequences of the genetic testing revolution. DNA tests have become so prevalent that more and more people are discovering they have rare and potentially dangerous or even lethal genetic mutations. But how accurate are those findings? And what should people and their doctors do about them? Michelle tells the story of one family faced with the decision whether to proceed with life-altering surgeries to avoid facing a cancer diagnoses one day in the future.
May 09, 2019
Why the Mormon Church Loves Your DNA
1588
A century-old quest for family records to unite relatives in heaven has transformed the church into a global leader in genealogy technology. That's paved the way for the success of companies like 23andMe who sell the promise of helping us figure out who are and where we come from.
Apr 25, 2019
Introducing "What Goes Up," A New Show From Bloomberg
148
On this new show from Bloomberg, hosts Mike Regan and Sarah Ponczek speak with expert guests each week about the main themes influencing global markets. They explore everything from stocks to bonds to currencies and commodities, and how each asset class affects trading in the others. Whether you’re a financial professional or just a curious retirement saver, What Goes Up keeps you apprised of the latest buzz on Wall Street and what the wildest movements in markets will mean for your investments. 
Apr 19, 2019
Building a Better Period-Tracking App
1692
On this episode of Prognosis, we'll meet the Bloody Health collective – a group of feminist coders in Berlin who are looking for a safer way to track their periods. Targeted advertising, third-party data sharing and tracking make most menstruation apps just as problematic as they are popular, privacy activists argue. For the women of Bloody Health, the sure way to keep control is to build their own open-source app.
Apr 11, 2019
Coming Soon: The Pay Check Season 2
122
The Pay Check is back for a second season! For the next six weeks, we’re going to dig into the number one reason women still make less money than men: Motherhood. Women start their careers earning just about the same as men do, but once they have their first kid, that pay gap grows to a chasm. This season, we’ll show you how this “motherhood penalty” plays out for real women, in real life and how it affects the global economy.
Apr 05, 2019
DNA Testing Is Changing Families
1525
On the latest edition of Prognosis, we'll tell you how a simple DNA genealogy test upended the life of a Washington state sheep farmer. Instead of finding out more about the Swedish and Jewish roots she'd heard about, she found that she had an entire family she didn't know about, and a connection to a man with a mysterious and controversial past. These types of genetic surprises are getting more common, and redefining who we call family.
Mar 28, 2019
Coming Soon: Prognosis Season 2
127
Prognosis is back for a second season. Over the next few weeks, we're acknowledging how science and technology are making it easier for us to know pretty much everything there is to know about ourselves: Where we come from. The best time to conceive. What might kill us. And what happens when we start getting all that information, and handing it over to others.
Mar 21, 2019
A Message from The Pay Check
83
The Pay Check is collecting stories for our upcoming season, and we want to hear from you! Did having a kid change your career trajectory or the way you work? If you have anything you want to share, call and leave us a voicemail at (212) 617-0166. Stay tuned for more very soon!
Feb 08, 2019
How to Buy a Cure
1545
Some patients can't wait for pharmaceutical companies to develop drugs. They're pushing the drug industry to make the cures they and their loved ones need. But what's good for patients is also good for pharma's profits, creating a web of murky incentives that makes the issue of high drug costs all the more difficult to parse. In episode 8, Bloomberg's Rebecca Spalding talks to these professional patients about their relationships to the big companies whose therapies they need.
Dec 24, 2018
Right to Try, Right to Fail
1526
Should a patient dying of a disease with no proven cure have the right to try whatever experimental drug they want? A controversial new law signed by President Trump this year says that they should, bypassing the FDA. In episode seven, Bloomberg's Michelle Fay Cortez explores what the new Right To Try law means for desperate patients who want access to experimental treatments. It isn't as simple as it sounds.
Dec 17, 2018
One Drug's Journey
1453
When you pick up your prescription at the pharmacy, do you ever wonder how that pill made it your way? Who discovered it? Who believed in it when no one else did? Who invested the money to bring it to market? This week on Prognosis, Bloomberg's Rebecca Spalding tells the surprising journey of one life-saving drug, from discovery to market. It's a story about a Nobel Prize winner, cutting edge genetic research, billions of pharmaceutical dollars, and of all things, a worm. What does it tell us about health care in America?
Dec 10, 2018
The Quest for a Weight-Loss Drug That Actually Works
1444
Researchers and pharmaceutical companies have poured time and money into developing an effective drug to combat obesity. But time and again, the drugs have failed to deliver. In episode five of Prognosis, Bloomberg's James Paton talks to scientists on the cutting edge of weight-loss research, and the companies that may finally be close to finding a medical solution to the obesity crisis.
Dec 03, 2018
Decoding the Genome Was Just the Beginning
1532
Eighteen years ago, scientists decoded the human genome. But what was supposed to create an era of new cures didn't work out that way, at least not at first. In episode four of Prognosis, some of the most famous names in genetics explain why it took so long to go from mapping life's code to actually helping people, laying the foundations for technologies on the scientific and ethical cutting edge, like modifying people's genes.  
Nov 26, 2018
Searching For a Cure to PTSD at Burning Man
1535
In episode three of Prognosis, Kristen V. Brown and Sarah McBride take a trip to Burning Man. They're there to follow Rick Doblin, who has become something of a folk hero for those who believe MDMA—Ecstasy—could be a viable clinical treatment for things like PTSD. But to help push an illegal drug into the mainstream, it takes lots of cash. And to find money for an unconventional treatment, what better place than Burning Man?
Nov 19, 2018
Biohacking a Ripped Frog
1666
If you had told people from the 1970s that few decades later the globe would be connected with powerful computers held in the palm of your hand, they could be forgiven for thinking you were seriously deluded. Now, a growing number of scientists are convinced we're on a similar threshold with genetic engineering. Today we'll take you on a tour of a biohacker's DNA experiment to change how frogs—and possibly people—grow muscles. It's an experiment which he insists anyone can try at home. He'll even sell you a kit—frogs included—to do it.
Nov 12, 2018
How To Build Your Own Artificial Pancreas
1584
More than a million Americans suffer from Type 1 diabetes. The disease occurs when the pancreas mysteriously stops producing insulin, the hormone that converts food into energy. Modern medicine has been able to recreate insulin, but not the finely calibrated delivery mechanism of the pancreas. Now a group of like-minded do-it-yourselfers have gotten together on the internet and—working outside the purview of organized medicine—have figured out how to link a pump, glucose monitor and smartphone to simulate a functioning pancreas. The results have been spectacularly successful.
Nov 05, 2018
Prognosis, a New Show From Bloomberg
136
Where does a medical cure come from? 100 years ago, it wasn't uncommon for scientists to test medicines by taking a dose themselves. As medical technologies get cheaper and more accessible, patients and DIY tinkerers are trying something similar—and mainstream medicine is racing to catch up. Prognosis explores the leading edge of medical advances, and asks who gets—or should get—access to them. We look at how innovation happens, when it fails, and what it means to the people with a disease trying to feel better, live longer, or avoid death.
Oct 24, 2018